Prostate Cancer Diagnostics - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Prostate Cancer Diagnostics Market is accounted for $3.20 billion in 2020 and is expected to reach $9.94 billion by 2028 growing at a CAGR of 15.2% during the forecast period. Increasing prevalence of prostate cancer, increasing awareness regarding early detection and availability of advanced methodologies present in the medical field are driving the market growth. However, high cost of diagnostics procedure, lack of skilled and certified professionals is hampering the growth of the market.
Prostate cancer is the cancer of abnormal and uncontrolled growth of cells in the prostate gland of a male which is a part of the male reproductive system, basically it is a small gland shaped like a walnut that produces seminal fluid that helps to maintain sperms and facilitates their transportation. It is the second-most common cancer occurring in men, after skin cancer. Prostate cancer diagnostics depend on several factors, such as how fast cancer is growing, whether it has spread to overall health, as well as the potential benefits or side effects of the treatment.
Based on the test type, the preliminary tests segment is going to have lucrative growth during the forecast period as easy availability of preliminary screening has facilitated early diagnosis and treatment, increasing survival rates. PSA tests are much useful to detect unrecognized and small tumors that may or may not develop into an advanced stage of cancer. As preliminary tests facilitate the detection of cancer before major symptoms appear, they are mostly recommended to most men over the age of 50 and those at risk of developing the disease.
By geography, North America is going to have high growth during the forecast period owing to an increase in incidence of prostate cancer, innovative healthcare solutions, advanced healthcare infrastructure, and rise in concerns about prostate issues around the region. According to the American society of clinical oncology, prostate cancer is the second-most prominent cause of death in the U.S among men suffering from various cancer types. Therefore prostate cancer diagnostics has a huge demand in the North America region.
Some of the key players profiled in the Prostate Cancer Diagnostics Market include Myriad Genetics, Inc., Abbott Laboratories, Genomic Health, Siemens Healthcare GmbH, Beckman Coulter, Inc., Biomérieux SA, Diasorin S.P.A., MDx Health, F. Hoffman-La Roche AG, Bayer AG, Johnson & Johnson, Sanofi, Ambry Genetics and OPKO Health, Inc.
• Recurrent/Advanced Prostate Cancer
• Castration-Resistant Prostate Cancer
• Localized Prostate Cancer
• Reagents & Consumables
Prostate Cancer Types Covered:
• Squamous Cell Cancer
• Small Cell Carcinoma
• Transitional Cell (or Urothelial) Cancer
• Prostatic Adenocarcinoma
• Ductal Adenocarcinoma
• Small Cell Prostate Cancer
• Acinar Adenocarcinoma
Sample Types Covered:
Test Types Covered:
• Blood-Based Assay
• Preliminary Tests
• Confirmatory Tests
• Age <55
• Age 55-75
Peer Groups Covered:
End Users Covered:
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Independent Diagnostic Laboratories
Sales Channels Covered:
• Direct Channel/Direct Tender
• Distribution Channels (Retail Sales)
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.